PT - JOURNAL ARTICLE AU - Mourad Belaouni AU - Elhoucine Malki AU - Rabii El Bahraouy AU - Bouchra El Maliki AU - Mohammed Er-Rami AU - Houcine Louzi AU - Khalid Lahmadi TI - ABO-RH blood group and risk of covid-19 in a moroccan population AID - 10.1101/2020.12.02.20242180 DP - 2020 Jan 01 TA - medRxiv PG - 2020.12.02.20242180 4099 - http://medrxiv.org/content/early/2020/12/04/2020.12.02.20242180.short 4100 - http://medrxiv.org/content/early/2020/12/04/2020.12.02.20242180.full AB - Introduction Given the rapid spread, significant morbidity and mortality associated with COVID-19, there has been scientific interest in obtaining data detailing the factors influencing the risk of COVID-19 infection. The aim of this study was to reveal a possible association between the ABO-RH system and the risk of COVID-19 in the Moroccan population.Materials and methods This is an analytical cross-sectional study. It was carried out on 1094 patients for the diagnosis of Covid-19 by Rt-PCR at the Moulay Ismaïl military hospital in the province of Meknes. All Rt-PCR negative individuals were used as a comparison group.Results Among the 1094 individuals who were diagnosed, RT-PCR for detection of SARS-CoV-2 was positive for 242 individuals. Comparison of the proportions of blood groups of the two groups showed that the proportion of blood group A in patients with COVID-19 was significantly higher than in people in the comparison group (P = 0.007), while the proportion of blood group O in patients with COVID-19 was significantly lower than in people in the control group (P = 0.017). Comparison of the Rh blood groups of the two groups did not find a significant association (P = 0.608).Conclusion As demonstrated by several previous studies, we concluded that blood group A was associated with a higher risk of acquiring COVID-19. Equally, the O blood group was associated with a lower risk of infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Moulay Ismail Military Hospital Scientific Advisory and Ethics Committee has determined that this study is exempt from approval for research on a human subject because the project does not involve intervention or interaction with individuals, and does not use personally identifiable information. All necessary patient / participant consent has been obtained and the appropriate institutional forms have been archived.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used to support the findings of this study are available from the corresponding author upon reasonable request.